Optiscan Imaging Limited

CHIA:OIL Stock Report

Market Cap: AU$137.8m

Optiscan Imaging Valuation

Is OIL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of OIL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate OIL's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate OIL's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for OIL?

Other financial metrics that can be useful for relative valuation.

OIL key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue42.5x
Enterprise Value/EBITDA-19.6x
PEG Ration/a

Price to Sales Ratio vs Peers

How does OIL's PS Ratio compare to its peers?

The above table shows the PS ratio for OIL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average4.9x
IPD ImpediMed
10.8x41.0%AU$109.2m
CYC Cyclopharm
6.5x42.7%AU$167.3m
AHC Austco Healthcare
1.6xn/aAU$91.0m
SOM SomnoMed
0.8x9.0%AU$73.5m
OIL Optiscan Imaging
46.2xn/aAU$137.8m

Price-To-Sales vs Peers: OIL is expensive based on its Price-To-Sales Ratio (46.2x) compared to the peer average (4.9x).


Price to Earnings Ratio vs Industry

How does OIL's PE Ratio compare vs other companies in the AU Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a16.1%
n/an/an/a
No. of CompaniesPS048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a16.1%
n/an/an/a
No more companies

Price-To-Sales vs Industry: OIL is expensive based on its Price-To-Sales Ratio (46.2x) compared to the Australian Medical Equipment industry average (3.4x).


Price to Sales Ratio vs Fair Ratio

What is OIL's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

OIL PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio46.2x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate OIL's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies